- Home
- HBCP vs OLMA Comparison
HBCP vs OLMA Comparison
Compare HBCP & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBCP
- OLMA
- Stock Information
- Founded
- HBCP 1908
- OLMA 2006
- Country
- HBCP United States
- OLMA United States
- Employees
- HBCP N/A
- OLMA N/A
- Industry
- HBCP Banks
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- HBCP Finance
- OLMA Health Care
- Exchange
- HBCP Nasdaq
- OLMA Nasdaq
- Market Cap
- HBCP 398.1M
- OLMA 383.1M
- IPO Year
- HBCP 2008
- OLMA 2020
- Fundamental
- Price
- HBCP $47.75
- OLMA $4.99
- Analyst Decision
- HBCP Buy
- OLMA Strong Buy
- Analyst Count
- HBCP 2
- OLMA 4
- Target Price
- HBCP $55.00
- OLMA $28.33
- AVG Volume (30 Days)
- HBCP 21.9K
- OLMA 1.0M
- Earning Date
- HBCP 04-16-2025
- OLMA 03-10-2025
- Dividend Yield
- HBCP 2.16%
- OLMA N/A
- EPS Growth
- HBCP N/A
- OLMA N/A
- EPS
- HBCP 4.51
- OLMA N/A
- Revenue
- HBCP $130,219,000.00
- OLMA N/A
- Revenue This Year
- HBCP N/A
- OLMA N/A
- Revenue Next Year
- HBCP $7.58
- OLMA N/A
- P/E Ratio
- HBCP $10.59
- OLMA N/A
- Revenue Growth
- HBCP N/A
- OLMA N/A
- 52 Week Low
- HBCP $33.30
- OLMA $4.60
- 52 Week High
- HBCP $52.77
- OLMA $16.62
- Technical
- Relative Strength Index (RSI)
- HBCP 42.34
- OLMA 38.98
- Support Level
- HBCP $48.93
- OLMA $4.94
- Resistance Level
- HBCP $52.77
- OLMA $5.34
- Average True Range (ATR)
- HBCP 1.15
- OLMA 0.42
- MACD
- HBCP -0.41
- OLMA -0.03
- Stochastic Oscillator
- HBCP 0.00
- OLMA 11.39
About HBCP Home Bancorp Inc.
Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities. The principal sources of funds are customer deposits, repayments of loans, repayments of investments and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans. Its primary expenses are interest expense on deposits and borrowings and general operating expenses.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.